Hunan Nucien Pharmaceutical Co (SHSE:688189) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688189 Hunan Nucien Pharmaceutical Co Ltd SHSE:688189
48 GF Score
Price ¥6.70
GF Value ¥2.34
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Hunan Nucien Pharmaceutical Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:688189
48GF Score
Hunan Nucien Pharmaceutical Co Ltd SHSE:688189
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hunan Nucien Pharmaceutical Co (SHSE:688189) Overvalued in 2026?

Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥6.70 is trading 186.3% above its estimated GF Value™ of ¥2.34. GuruFocus considers Hunan Nucien Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:688189:

  • FFO:
  • GF Value™: ¥2.34 vs. price of ¥6.70 (186.3% above fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hunan Nucien Pharmaceutical Co Business Description

Address No. 1 Kangli Road, Liuyang Economic and Technological Development Zone, Hunan Province, Changsha, CHN, 510100
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields. The company's business scope includes the manufacturing and sales of chemical pharmaceutical preparations, chemical pharmaceutical raw materials, biological drugs, chemical reagents, and auxiliaries.
48GF Score

Get the complete analysis for SHSE:688189

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.70
Price
¥2.34
GF Value